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Abstract: Recurrent binge eating episodes, the core feature of Bulimia Nervosa (BN) and Binge Eating
Disorder (BED), are frequently comorbid with obesity. Psychological interventions, notably Cognitive
Behavioural Therapy (CBT), are effective for binge eating reduction in BED or BN but less so for
weight loss. Behavioural Weight Loss Therapy (BWLT) shows effectiveness for binge eating reduction
and weight loss but the latter appears poorly sustained over time. Our aim was to review evidence
for efficacy of psychological therapies for BN/BED associated with overweight or obesity in reducing
binge frequency and weight. A systematic search for randomized controlled trials with adult samples
who had BN or BED was conducted considering articles in English, French, Spanish and Portuguese
with no restrictions for the timeline publication ending in March 2016. A quality appraisal of the
trials and meta-analyses comparing BWLT to CBT were done. This review identified 2248 articles for
screening and 19 published articles were selected. No trials of BN were identified. This review found
CBT was favoured compared to BWLT with regard to short-term binge eating reduction. However,
insufficient evidence was found for superiority for BWLT efficacy compared to CBT considering
binge eating remission, reduction of binge eating frequency and weight loss. More research is needed
to test the efficacy of psychological treatments for BED or BN with co-morbid overweight or obesity,
including trials evaluating binge eating remission and weight loss in the long-term.
Keywords: obesity; binge eating; psychotherapy; weight management
1. Introduction
Eating disorders (EDs) are severe conditions that occur across age groups and in both sexes [1].
Worldwide, they occur most frequently in young women, with prevalence rates that can be up to
10% in community populations [2,3]. The most common are Bulimia Nervosa (BN) and Binge Eating
Disorder (BED) [3,4]. Recurrent binge eating episodes are the core feature of both conditions and
these are characterized by the consumption of an unusually large amount of food associated with
the sense of loss of control over eating during the episode [5]. BN and recurrent binge eating are
both increasing and are associated with considerable impairment, both psychological and physical,
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including overweight or obesity [2,6–8]. The recently published Noncommunicable Diseases NCD
Risk Factor Collaboration that used 1698 population-based data sources encompassing 186 countries
reported large increases in global age-standardised mean Body Mass Index (kg/m2, BMI) from 1975 to
2014 [9]. As described by the researchers, in this period, men’s mean BMI changed from 21.7 kg/m2 to
24.4 kg/m2, and women’s mean BMI increased from 22.1 kg/m2 to 24.4 kg/m2. If this trend persists,
the authors estimate that, in 2025, the global obesity prevalence will be 18% in men and above 21% in
women. The relationship between binge eating and obesity is complex and likely bidirectional [10].
An Australian community study that examined the increase in prevalence rates of ED’ behaviours and
obesity over the 10-year period from 1995 to 2005 reported that rates of obesity associated with ED’
behaviours increased from 8.5% to 20% [7]. The findings of increasing rates of these two conditions
together support the need for the development of effective approaches to prevent and to treat them,
especially when they co-occur.
In a 2012 study, Bulik et al. [11] reported that during the course of a trial comparing group
Cognitive Behavioural Therapy (CBT) versus online CBT for patients with BN, there was an increase in
weight, with individuals reaching the overweight or obesity ranges. The authors argued that in face of
the rise of obesity worldwide the appearance of overweight or obesity in individuals with BN should
not be unexpected. Indeed, the National Comorbidity Survey Replication reported a point prevalence
of 20.9% for BMI ≥ 30 kg/m2 and 10.3% for BMI ≥ 40 kg/m2 in individuals with a lifetime diagnosis
of BN [12].
The treatment of obesity is challenging. The Australian Guidelines for the management of
obesity consider the most effective treatment (based on a weight loss above 10% of baseline weight
that is maintained over five years) is achieved by bariatric surgery; moderate effectiveness is found
with pharmacotherapy plus lifestyle change (diet, physical activity or psychological therapy) and
lifestyle change alone has the lowest effectiveness [13]. As for EDs, a systematic review examined
available psychological therapies and concluded that the best evidence for the treatment of BN was
a therapist-led CBT [14]. For BED, CBT in full or as guided self-help intervention had the greatest
support, but for patients with BED associated with obesity, behaviour weight loss therapy (BWLT)
appeared to be an alternative to CBT, at least in the short-term [14]. A further systematic review
reported that even very low calorie diets may be beneficial for individuals with BED [15]. Another
recent review found CBT and Interpersonal Therapy (IPT) to be the most effective treatments for binge
eating reduction over the short and long term for patients with BED [16]. However, these last two
approaches do not target weight loss. On the other hand, BWLT has shown effectiveness for binge
eating reduction associated with weight loss in the short term, but this was poorly sustained over
time [17].
Hence, the aim of this systematic review was to investigate the efficacy of psychological therapies
for the treatment of BN and BED associated with overweight or obesity, with a special focus on the
effects of BWLT as this is the only therapy currently developed to reduce both binge eating and weight.
We planned meta-analyses of studies that compared BWLT versus no treatment or wait-list, and BWLT
versus another psychological therapy. The primary outcomes of interest in the meta-analyses were
binge eating frequency and weight/BMI. As weight loss in obesity trials is now routinely reported to
one year, this was a second specific outcome [18] and a third was treatment completion as attrition is
a source of bias and completion may be a proxy for acceptability.
2. Materials and Methods
2.1. Literature Search Strategies
The Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guideline
was used for the conduct of this systematic review [19]. A search of published academic journal articles
was conducted in indexed journals of seven electronic databases: MEDLINE, PsycINFO, WEB OF
SCIENCE, SCOPUS, COCHRANE, EMBASE E LILACS from 18 January 2016 to 8 March 2016 using the
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following terms: (bulimia nervosa OR binge eating disorder OR eating disorders OR bulimia OR binge
eating OR binging) NOT (anorexia nervosa OR binge drinking) AND (overweight OR obesity) AND
(psychotherapy OR therapeutics OR cognitive therapy OR psychological therapy OR psychological
treatment) NOT (drug therapy OR pharmacological treatment).
Additional searches were made through the reference list of papers selected. Unpublished papers
were searched through the ProQuest Dissertations and Theses in Western Sydney University library in
21 October 2016.
2.2. Selection Criteria
The inclusion criteria for studies in this review were randomized controlled trials that investigated
the efficacy of behavioural weight loss and other psychological therapies for the treatment of
individuals with BED or BN associated with overweight or obesity. Studies that evaluated
psychological interventions such as CBT, Cognitive Behavioural Therapy-Enhanced (CBT-E), IPT,
BWLT, Behaviour Therapy, short-term focal psychotherapy, Dialectical Behaviour Therapy (DBT),
self-help therapy, analytic psychotherapy, meditation, mindfulness, or any other psychological therapy
were included. Trials that compared two or more forms of psychological therapy or a psychological
therapy compared to a wait-list/delayed treatment or to placebo were included. Only articles in
English, French, Spanish and Portuguese were considered with no restrictions for the timeline
publication. Three authors (MAP, CASF, and AC) are fluent in Portuguese, written Spanish and
French, and a fourth is a native English speaker (PH).
Trials included in this review involved: (i) adults (≥18 years old) of both genders; (ii) individuals
diagnosed with BN, or BED, or Eating Disorder Not Otherwise Specified (EDNOS)-BN/BED type [20],
or Other Specified Feeding or Eating Disorder (OSFED)-BN/BED according to a valid diagnostic
scheme such as the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text
Revised (DSM-IV-TR) [20], or DSM-5 [5], or the International Statistical Classification of Diseases
and Related Health Problems 10th Revision (ICD-10) [21], or the proposed ICD-11 [22], based either
on a validated instrument (e.g., Eating Disorder Examination) [23], or specialist clinician judgment;
(iii) studies where at least 90% of the participants had a BMI ≥ 27 kg/m2; and (iv) patients treated
in primary, secondary or tertiary outpatient care. Exclusion criteria included studies developed in
inpatient or partial hospital facilities where it is not possible to determine specifically the effect of the
psychological approach in a complex multi-treatment environment and studies examining secondary
questions such as predictors of outcomes (termed “secondary studies”). Literature reviews, book
chapters, conference annals, theoretical articles, and studies of pharmacological treatment, bariatric
surgery, exercise alone or another non-psychological therapy were also excluded.
Two reviewers (MAP and CASF) independently examined the titles and abstracts of the citations
that emerged from the researches and selected articles to be fully reviewed by both for the definition of
those that fulfilled the purposes of this review. Two further senior authors’ opinions (AMC and PH)
were requested when consensus was not achieved by the two reviewers. All the authors are clinicians
and researchers in the field of EDs.
Data extracted from papers were: year of publication, demographic features of participants,
participant diagnoses and method of ascertainment, sample size and interventions’ time points of
assessment. Data were extracted by MAP and checked for accuracy by the other authors.
2.3. Quality Assessment
Data extracted for appraisal of trial quality were the method of diagnostic ascertainment and
main outcome of binge frequency, sample size and a priori power analysis, risk of bias, blinding, and
length of follow-up (≥12 months). A consensus on trial quality was made between two authors (MAP
and PH). The overall risk of bias across studies was defined as: (i) high when the information of the
studies at risk of bias was sufficient to affect the interpretation of the results; (ii) low when the available
information was sufficient not to affect the interpretation of the results; and (iii) unclear when the
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information was not clearly specified or even reported. Attrition >20% was considered moderate and
>50% was considered high [24].
2.4. Outcome Measures
Outcome measures selected for this review were: (1) binge eating frequency or binge
remission—measured as number of binges in the last week, month or three months; (2) weight or BMI,
both measured at end-of-treatment and at one-year follow-up; and (3) treatment completion rates.
2.5. Meta-Analyses
As this systematic review had a special interest in the effects of BWLT as an intervention to
treat BN or BED associated with overweight, we performed meta-analyses aggregating studies where
BWLT was tested in one of the arms and compared with another psychological therapy, or to wait-list,
or no treatment. Conducted meta-analyses examined the primary outcomes binge eating frequency
(one week, one month, or three months) and weight (kg)/BMI (kg/m2). Additional meta-analyses
investigated treatment and follow-up completion rates.
The Review Manager Program (RevMan 5.3) was used for all analyses [25]. Mean difference
analyses were conducted for continuous outcome data, together with 95% confidence intervals (CI).
(Standardised mean differences were to be used where there were different measures of outcome,
e.g., weight rather than BMI.) Risk ratio (RR) was used for differences in the categorical outcome of trial
completion. Where more than one type of psychotherapy was included in a trial for comparison against
BWLT (the treatment of main interest in this review), we have chosen the CBT arm to make comparisons
as this is the therapy considered to have stronger evidence of efficacy [26]. Heterogeneity was assessed
using the I-squared (I2) test, which provides an estimate of the percentage of variability due to
heterogeneity rather than chance alone, with a value >50% considered substantial heterogeneity [24].
A random effects or fixed effects model was applied as appropriate.
Authors were contacted to provide information not available in the published study, including
information needed for for quality evaluation of the trials and to obtain the results of unpublished or
partly published trials. Where authors responded, it is reported with the information supplied.
3. Results
The literature search identified 2248 articles, of which 543 were duplicate papers. From 1705
papers, 1650 were excluded after title and/or abstract inspection, and 36 excluded after full article
inspection. Nineteen articles were included in this review. Thirteen published articles provided full
information for data extraction [17,27–38], and six further trials were included but had incomplete
information, i.e. inclusion under 10% of participants with BMI ≤ 27 kg/m2 and/or the EDs’ diagnosis
was not determined by a validated instrument [39–44]. Just one secondary study was included due to
assessment of a long-term intervention (up to six-year follow-up) [35]. These results are illustrated in
Figure 1. The most common reason for excluding full text articles was not being randomized (n = 11),
followed by participants not having a diagnosis of BN, BED or subthreshold forms of these disorders
(n = 6). A table with the excluded articles followed by the references list is added as Supplementary
Material Table S1.
3.1. Characteristics of Included Trials
Table 1 summarizes the main features of the 19 included randomized controlled trials. All trials
were reported in English and none were set outside North America or Europe [17,27–44]. Fifteen
articles included participants with BED [17,27–30,33–35,38–44], and four included participants with
mixed full and subthreshold BED (i.e., EDNOS or OSFED) [31,32,36,37]. There were no trials including
participants with BN or subthreshold BN. The majority (n = 16) of the trials included both men and
women, but women comprised at least 67% of participants in any trial [17,27,29–41,44]. Participant
mean age ranged from 37.6 to 52.3 years, mean BMI ranged from 32.2 to 41.1 kg/m2 and two trials
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included a small (10% or fewer) number of participants with BMI ≤ 27 [40,44]. The sample size ranged
46–205, and all but two studies had more than 50 participants [31,41]. One trial [27] used the DSM-5
diagnostic classification system, and the remainder the DSM-IV, and none used ICD-10. The main
instruments used for diagnosis were the Structured Clinical Interview for DSM-IV Axis I Disorders
Patient Version (SCID-I/P) [45], and the EDE [23].
Records identified  through 
database searching 
 
N = 1830 
Additional records identified through 
reference list 
 
Reference list          N = 0 
ProQuest                 N = 418 
Total of records identified 
 
N = 2248 
Duplicates removed 
 
N = 543 
 
Records screened 
 
N = 1705 
Records excluded by 
title and abstract 
 
N = 1650 
Full-text articles assessed 
 for elegibility 
 
N = 55 
Trials included 
 
N = 19 articles 
Full-text articles excluded 
 
N = 36 
 
Not randomised (11) 
Not having threshold or 
subthreshold BN, BED 
diagnosis (6) 
Not all BMI≥27 or unclear 
BMI≥27 (6) 
Secondary studies (4) 
Inpatient trial (2) 
Paper not found (2) 
Protocol only (1) 
Not psychotherapy (1) 
Meta-analysis (1) 
Included non eating 
disorder binge  eters (1) 
BN non obese (1) 
 
                          Figure 1. Prisma flow chart of study inclusion. Figure 1. Prisma flow chart of study inclusion.
3.2. Quality Appraisal of Included Trials
Only 10 (53%) trials reported follow-up to ≥12 months. Table 2 describes the further quality
appraisal of each included trial providing detailed information from studies. Seven trials reported
an a priori power analysis as shown with a # symbol [17,27,28,30,32,33,36].
Table 3 summarizes the global findings regarding the methodological quality of trials included in
this review, considering high, low or unclear risks of bias. The majority (n = 16) of trials had overall
unclear risk of bias and high (n = 10) or unclear (n = 9) risk of bias due to lack of adequate blinding.
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Table 1. Features of included randomized controlled trials.
Trial Sample
Diagnostic
Criteria/Classification
System (Instrument)
Intervention
Time Point of Assessments
Relative to the Start of the
Interventions
End of Treatment Outcomes
(Binge Remission/Frequency and
BMI/Weight Loss)
Follow-Up of Active
Treatments Outcomes
(Binge Remission/Frequency
and BMI/Weight Loss)
Trials which all participants had BMI≥ 27 and the eating disorder diagnosis was determined by a validated instrument
Alfonsson et al.
Sweden/2015 [27]
n = 100#
94%♀/6%♂Mean age
44.3 Mean BMI 41.1
BED/DSM-5 (EDE)
1. Behavioural activation
2. Delayed treatment
Group sessions
Baseline
EoT 10 weeks
FU 3–6 months
No differences between
groups in binge eating frequency.
No BMI results.
Only for active
treatment—no comparison.
Gorin et al.
USA/2003 [28]
n = 94# 100%♀Mean
age 45.2 Mean BMI
39.42
BED/DSM-IV
(SCID-I/P)
1. Standard cognitive
behavioural therapy
2. CBT-spouse involvement
3. Delayed treatment
Group sessions
Baseline
EoT 12 weeks
FU 6 months
Comparison between active
treatments: no differences in binge
eating frequency or BMI. Active
treatments compared to wait-list:
better results for binge eating
frequency and BMI for CBT groups.
Only comparison between active
treatments: no differences in
binge eating frequency or BMI.
Grilo and Masheb
USA/2005 [29]
n = 90
79%♀/21♂Mean age
46.3 Mean BMI 35.5
BED/DSM-IV
(SCID-I/P+EDE)
1. CBTgsh
2. BWLgsh
3. Self-monitoring control
Individual sessions
Baseline
EoT 12 weeks
CBTgsh had greater results for binge
eating frequency compared to
BWLgsh and the control. No
differences between groups for BMI.
No follow-up.
Grilo et al.
USA/2011 [30]
n = 125#
67%♀/33%♂Mean
age 44.8 Mean
BMI 38.8
BED/DSM-IV
(SCIDI/P+ EDE)
1. CBT
2. BWL
3. CBT + BWL
Group sessions
Baseline
EoT 24 weeks
(CBT and BWL)
FU 6–12 months
No differences between groups in
binge remission and binge eating
frequency. BWLT and CBT + BWL
had significant greater per cent BMI
loss than CBT.
No differences between groups
in binge remission rates. Binge
eating frequency significantly
lower in CBT than BWL at both
follow-up. At six-month
significant BMI loss in BWL than
CBT, but not sustained at
12-month.
Grilo et al.
USA/2013 [31]
n = 48
79%♀/21%♂Mean
age 45.8 Mean
BMI 37.62
Threshold and
subthreshold
BED/DSM-IV
(SCID-I/P + EDE)
1. Self-help CBT
2. Usual care Self-help
Baseline
EoT 4 months
No differences between groups in
binge remission, frequency of binge
eating or BMI.
No follow-up.
Kristeller et al.
USA/2014 [32]
n = 150#
88%♀/12%♂Mean
age 46.5 Mean
BMI 40.2
Threshold and
subthreshold
BED/DSM-IV-R
(EDE)
1. Mindfulness-based
eating awareness training
2. Psychoeducational
cognitive-behavioural
treatment
3. Delayed treatment
Group sessions
Baseline
EoT 1 month
FU 4 months
Comparison between active
treatments: no differences in binge
eating frequency or BMI. Active
treatments compared to wait-list:
better results for binge eating
frequency and BMI for both
active interventions.
Same results found at end
of treatment.
Masheb et al.
USA/2011 [33]
n = 50#
76%♀/24♂Mean age
45.8 Mean BMI 39.1
BED/DSM-IV-TR
(SCID-I/P+EDE)
1. CBT + low-energy-
density diet
2. CBT + general nutrition
Individual sessions
Baseline
EoT 6 months
FU 12 months
No differences between groups in
binge remission or BMI.
Same results found at end
of treatment.
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Table 1. Cont.
Trial Sample
Diagnostic
Criteria/Classification
System (Instrument)
Intervention
Time Point of Assessments
Relative to the Start of the
Interventions
End of Treatment Outcomes
(Binge Remission/Frequency and
BMI/Weight Loss)
Follow-Up of Active
Treatments Outcomes
(Binge Remission/Frequency
and BMI/Weight Loss)
Munsch et al.
Switzerland/2007 [34]
and Munsch et al.
Switzerland/2012 [35]
n = 80
89%♀/11%♂Mean
age 46.1 Mean BMI
34.0 n = 52
90%♀/10%♂Mean
age 52.3 Mean
BMI 32.5
BED/DSM-IV-TR
(EDE)
BED/DSM-IV-TR
(EDE-Q)
1. CBT
2. BWLT Group sessions
Baseline
EoT 4 months
FU 12 months FU 6 years
CBT improved significantly for
binge remission and binge eating
frequency. However, BWLT was
significantly better in weight loss.
No differences between groups
in binge remission, binge eating
frequency or BMI. Comparing
the end of treatment to six-year
follow-up, these outcomes
significantly worsened.
Comparing the baseline to
six-year follow-up these
measures still improved with
medium to large effect sizes.
Ricca et al.
Italy/2010 [36]
n = 144#
86%♀/14%♂Mean
age 46.9 Mean
BMI 38.1
Threshold and
subthreshold
BED/DSM-IV
(SCID-I/P)
1. Individual CBT
2. Group CBT
Baseline
EoT 24 weeks for I-CBT 22
weeks for G-CBT
FU 3 years
No differences between groups in
reduction of binge eating episodes
and BMI.
Same results found at end
of treatment.
Shapiro et al.
USA/2007 [37]
n = 66
92%♀/8%♂Mean age
39.5 Mean BMI 37.3
Threshold and
subthreshold
BED/DSM-IV
(SCID-I/P)
1. Group CBT
2. CD-ROM
3. Delayed treatment
Baseline
EoT 10 weeks
FU 2 months
No differences between groups in
binge eating frequency or BMI.
Same results found at end
of treatment.
Wilfley et al.
USA/2002 [38]
n = 162
83%♀/17%♂Mean
age 45.2 Mean
BMI 37.4
BED/DSM-IV (SCID
for DSM-III-R + EDE)
1. CBT
2. Interpersonal therapy
Group sessions + three
individual sessions
Baseline
EoT 20 weeks
FU 4–8–12 months
No differences between groups in
binge eating frequency or BMI.
Same results found at end
of treatment.
Wilson et al.
USA/2010 [17]
n = 205#
79%♀/21%♂Mean
age 48.4 Mean
BMI 36.4
BED/DSM-IV
(SCID-I + EDE)
1. CBTgsh
2. Interpersonal therapy
3. BWLT Individual
sessions for Interpersonal
therapy and BWLT
Baseline
EoT 24 weeks
FU 12–24 months
No differences between groups in
binge remission and binge eating
frequency. BWLT was significantly
more effective in BMI reduction than
the two other treatments.
1-year FU: no differences
between groups in measures of
binge eating and more significant
BMI gain for the BWL group
compared to CBTgsh group.
Two-year FU: IPT and CBTgsh
were more effective for remission
of binge episodes. No difference
for BMI comparing all groups.
Trials which included under 10% participants with BMI≤ 27 and/or the eating disorder diagnosis was not determined by a validated instrument
Agras et al.
USA/1995 [39]
n = 50
86%♀/14%♂Mean
age 47.6 Mean
BMI 37.1
BED/not specified
(Structured clinical
interview)
1. CBT 12 weeks followed
by 12 weeks of either IPT
for non -responders or
weight loss therapy for
responders to CBT
2. Delayed treatment
Group sessions
Baseline
EoT 24 weeks
Active treatment compared to
wait-list: better results for binge
eating frequency and BMI for active
intervention. IPT group: binge
eating increased and weight
increased with IPT not significant.
Weight loss therapy: significant
weight loss and maintained reduced
binge eating.
No follow-up.
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Table 1. Cont.
Trial Sample
Diagnostic
Criteria/Classification
System (Instrument)
Intervention
Time Point of Assessments
Relative to the Start of the
Interventions
End of Treatment Outcomes
(Binge Remission/Frequency and
BMI/Weight Loss)
Follow-Up of Active
Treatments Outcomes
(Binge Remission/Frequency
and BMI/Weight Loss)
Dingemans et al.
Netherlands/ 2007 [40]
n = 52
94%♀/6%♂Mean age
37.6 Mean BMI 39.0
n = BMI < 27 *
BED/DSM-IV
(Instrument not
specified)
1. CBT
2. Delayed treatment
Group sessions
Baseline
EoT 20 weeks
FU 12 months
Significant binge remission and
reduction in frequency in binge
eating in CBT group. No significant
BMI change.
Only for active
treatment—no comparison.
Eldredge et al.
USA/1997 [41]
n = 46
96%♀/4%♂Mean age
45.2 Mean BMI 38.4
BED (No other
information)
1. CBT
2. Delayed treatment
Group sessions
Baseline
EoT 12 weeks
FU 24 weeks
Significant binge remission and
reduction in frequency in binge
eating in CBT group. No significant
BMI change.
No information.
Nauta et al.
Netherlands/2000 [42]
n = 74 100% ♀Mean
age 38.3 Mean BMI
33.1 Mixed sample of
binge eating and
non-binge eating
participants
BED/DSM-IV
(Structured interview)
1. Cognitive treatment
2. Behavioural treatment
Group sessions
Baseline
EoT 15 weeks
FU 6 months
At post-treatment 67% binge
abstinence with cognitive treatment
vs. 44% abstinence with behavioural
treatment in obese binge eating
participants. Other outcomes not
reported separately for binge
eating participants.
86% binge abstinence with
cognitive treatment vs. 44%
abstinence with behavioural
treatment in obese binge eating
participants (significant p < 0.01).
Pendleton et al.
USA/2002 [43]
n = 114 100% ♀Mean
age 45.0 Men
BMI 36.2
BED (no other
information)
1. CBT + exercise +
maintenance
2. CBT + exercise −
maintenance
3. CBT − exercise +
maintenance
4. CBT − exercise −
maintenance Group
sessions
Baseline
EoT 4 months
FU 6–12 months
Exercisers had significantly greater
reduction in binge frequency and
BMI compared to non-exercisers
groups. Addition of the maintenance
program did not influence on binge
eating behaviour but influenced
changes in BMI.
Same results found at end
of treatment.
Safer et al.
USA/2010 [44]
n = 101 85%♀/15%♂Mean age
52.2 Mean BMI 36.3
n = 9 BMI < 27 *
BED/DSM-IV (EDE)
1. Dialectical behaviour
therapy adapted for binge
eating (DBT-BED)
2. Active comparison
group therapy (ACGT)
Group sessions
Baseline
EoT 21 weeks
FU 3, 6, and 12 months
DBT-BED group achieved significant
reduction in binge frequency than
ACGT group. No differences found
between groups for BMI.
No differences between groups
in binge eating frequency or BMI.
Note: BED: binge eating disorder; BMI: body mass index; BWLgsh: behavioural weight loss – guided self-help; BWLT: behavioural weight loss treatment; CBT: cognitive behavioural
therapy; CBTgsh: cognitive-behavioural therapy—guided self-help; EDE: eating disorder examination; EDE-Q: eating disorder examination questionnaire; DSM: diagnostic and statistical
manual of mental disorders; EoT: end of treatment; FU: follow-up; SCID-I/P: Structured Clinical Interview for DSM-IV Axis Disorders Patient Version; * Unpublished information on
participant BMI numbers provided by author; #: Included a priori power analysis; ♀: women, ♂: men.
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Table 2. Quality appraisal of the nineteen included trials.
Reference Randomisation and AllocationConcealment Blinding Treatment Attrition Reporting Bias
Overall Risk of Bias
(Modal Assessment)
Trials which all participants had BMI > 27 kg/m2 and the eating disorder diagnosis was determined by a validated instrument
Alfonsson et al. #
2015 [27]
Adequate randomisation
Unclear allocation concealment
Unclear RoB
No blinding
High RoB
EoT 32%
Unclear RoB
Used ITT MEM
Trial registration not reported
Unclear RoB
Unclear
Gorin et al. # 2003 [28]
Unclear randomisation and
allocation concealment
Unclear RoB
No blinding
High RoB
EoT not reported
Assessment attrition 34%
Unclear RoB
Used ITT/LOCF
Participant flow not reported
Trial registration not reported
Unclear RoB
Unclear
Grilo and Masheb
2005 [29]
Adequate randomisation
and allocation concealment
Low RoB
No blinding except for
participant expectations
High RoB
EoT 22%
Attrition higher (33%) in
BWLgsh
Unclear RoB
Used ITT/LOCF
Participant flow reported
Trial registration not reported
Unclear RoB
Unclear
Grilo et al. # 2011 [30]
Adequate randomisation
Unclear allocation concealment
Unclear RoB
No blinding
High RoB
EoT 31%
Unclear RoB
Used ITT/MEM
Participant flow reported
Trial registered, outcomes unchanged from protocol
Low RoB
Unclear
Grilo et al. 2013 [31]
Adequate randomisation and
allocation concealment
Low Rob
Outcome assessment assessor blind
Participants could not be blind
Unclear RoB
No EoT attrition
Low RoB
Used ITT/MEM
Participant flow reported
Trial registration not reported
Unclear RoB
Unclear
Kristeller et al. # 2014 [32]
Inadequate randomisation
Unclear allocation concealment
High RoB
Unclear blinding
Unclear RoB
Attrition 30% greater in
control conditions but
not significant
Unclear RoB
Used ITT/MEM
Participant flow reported
Trial registration not reported
Unclear RoB
Unclear
Masheb et al.# 2011 [33]
Adequate randomisation
and allocation concealment
Low Rob
Outcome assessment assessor blind
Participants not reported blind
Unclear RoB
EoT 14%
Low RoB
Used ITT/MEM/LOCF
Participant flow reported
Trial registration reported
Low RoB
Low
Munsch et al. 2007 [34]
/2012 [35]
Unclear randomisation and
allocation concealment
Unclear RoB
Outcome assessment assessor not blind
Participants blind unclear
High RoB
EoT 27.5%
Unclear RoB
Used ITT/LOCF and completer for univariate models
Participant flow reported
Trial registration not reported
Unclear RoB
Unclear
Ricca et al. # 2010 [36]
Adequate randomisation
and allocation concealment
Low Rob
Outcome assessment assessor blind
Participants could not be blind
Unclear RoB
EoT 4.9%
Low RoB
Used ITT/LOCF
Participant flow reported
Trial registration not reported
Unclear RoB
Unclear
Shapiro et al. 2007 [37]
Unclear randomisation and
allocation concealment
Unclear RoB
Outcome assessment not blind
Participants could not be blind.
High RoB
EoT 41%
High RoB
Used ITT/MEM
Participant flow not reported
Trial registration not reported
Unclear RoB
High
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Table 2. Cont.
Reference Randomisation and AllocationConcealment Blinding Treatment Attrition Reporting Bias
Overall Risk of Bias
(Modal Assessment)
Wilfley et al. 2002 [38]
Unclear randomisation and
allocation concealment
Unclear RoB
Blinding only for treatment
fidelity assessment
Assessors not consistently blind
Participants blind unclear
High RoB
EoT 9.9%
Low RoB
Used ITT method unclear and completer analyses
Participant flow reported
Retrospective trial registered
Unclear RoB
Unclear
Wilson et al. # 2010 [17]
Adequate randomisation
Unclear allocation concealment
Unclear RoB
Outcome assessment assessor blind
Participants blinding unclear
Unclear RoB
EoT 23.1%
EoT Attrition 7% IPT/28%
BWL/30% CBTgsh
IPT significant lower attrition
Unclear RoB
Used ITT/MEM
Participant flow reported
Trial registration reported
Low RoB
Unclear
Trials which either did not use a validated instrument for eating disorder diagnosis and/or included under 10% participants with BMI < 27 kg/m2
Agras et al. 1995 [39]
Unclear randomisation and
allocation concealment
Unclear RoB
Unclear blinding
Unclear RoB
EoT 12.8%
Low RoB
Used ITT/LOCF and completer only analysis
Participant flow not reported
Trial registration not reported
Unclear RoB
Unclear
Dingemans et al. 2007 [40]
Unclear randomisation
Adequate allocation concealment
Unclear RoB
Assessor blind to group
Participants could not be blind
Unclear RoB
EoT 7%
Low RoB
Used MLA analysis
Participant flow reported
Trial registration not reported
Unclear RoB
Unclear
Eldredge et al. 1997 [41]
Unclear randomisation and
allocation concealment
Unclear RoB
No blinding
High RoB
EoT 19%
Low RoB
No ITT reported
Participant flow not reported
Trial registration not reported
High RoB
High
Nauta et al. 2000 [42]
Unclear randomisation and
allocation concealment
Unclear RoB
Blind not reported
High RoB
EoT 13.5%
Low RoB
Used ITT repeated-measures multivariate and
univariate analysis of variance
Participant flow not reported
Trial registration not reported
Unclear RoB
Unclear
Pendleton et al. 2002 [43]
Unclear randomisation and
allocation concealment
Unclear RoB
Unclear blinding
Unclear RoB
EoT attrition
unclear
Assessment attrition 22.8%
Unclear RoB
Not used ITT
Participant flow not reported
Trial registration not reported
High RoB
Unclear
Safer et al. 2010 [44]
Unclear randomisation and
allocation concealment
Unclear RoB
No blinding reported
Unclear RoB
EoT 19% but higher 33% in
control group and 10% in DBT
Unclear RoB
Used linear mixed models analysis
Participant flow reported
Trial registered
Low RoB
Unclear
Note: DBT: dialectical behaviour therapy; EoT: end of treatment; GEE: generalized estimating equation; BWLgsh: guided self-help behavioural weight loss; ITT: intention-to-treat; LOCF:
last observation carried forward; MEM: mixed effect model; MLA: multilevel analysis; #: Included a priori power analysis.
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Table 3. A synthesis of the quality appraisal of the nineteen included trials.
High Risk Low Risk Unclear Risk
Randomisation and Allocation Concealment
n = 1 n = 4 n = 14
[32] [29,31,33,36] [17,27,28,30,34,35,37,44]
Blinding n = 10 n = 0 n = 9
[27–30,34,35,37,38,41,42] [17,31–33,36,39,40,43,44]
Treatment Attrition
n = 1 n = 8 n = 10
[37] [31,33,36,38–42] [17,27–30,32,34,35,43,44]
Reporting Bias n = 2 n = 4 n = 13
[41,43] [17,30,33,44] [27–29,31,32,34–40,42]
Overall Risk of Bias (Modal Assessment)
n = 2 n = 1 n = 16
[37,41] [33] [17,27–32,34–36,38–40,42–44]
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3.3. Results of Studies Comparing Psychological Interventions for Binge Eating Disorder Associated
with Obesity
The most frequently tested intervention was CBT (15 studies) [17,28–34,36–41,43], followed
by BWLT (n = 4 studies) [17,29,30,34], and IPT (2 studies) [17,38]. A form of behavioural therapy
(e.g., behavioural activation and behavioural treatment) was tested in two studies [27,42]; DBT was
evaluated in one trial [44]; and other types of interventions were examined in four trials [31,32,37,44].
Three trials compared CBT versus a delayed treatment and all studies reported better results
for binge remission and frequency of binge eating [39–41] with CBT. For weight loss, two studies
reported no difference between groups [40,41], and one study reported better results for weight loss
favouring CBT [39]. CBT was also compared to other psychological interventions in three two-armed
trials (versus CBT-spouse involvement, versus mindfulness, and versus IPT) [28,32,38], usual care
in one trial [31], and CD-ROM-Based CBT in one trial [37]; in all of these studies, no between active
treatment groups differences for frequency of binge eating and weight loss were reported. CBT
plus low-energy-density dietary was compared to CBT plus general nutrition counselling where no
differences for binge remission or weight loss were found [33]. One study investigated the effects
of individual versus group CBT but found no differences in efficacy for reduction of binge eating
or BMI [36]. One study compared CBT only to CBT combined with exercise, or to maintenance
intervention, or to both, and reported that the groups with CBT plus exercise had greater reductions in
binge remission, frequency of binge eating and BMI compared to the non-exercise groups [43].
In sum, in terms of end of reduction of binge eating remission or frequency, CBT was superior
to a delayed treatment control in three studies, not superior to an active intervention in seven trials,
and inferior to CBT combined with exercise in one trial (excluding here the BWLT trials which will be
specified separately). In terms of reduction in weight/BMI, CBT was not superior to delayed treatment
in two of three trials, and not superior to an active intervention in seven trials, and inferior to CBT
combined with exercise in one trial [28,31–33,36–41,43].
Besides CBT, DBT presented better results at the end of treatment for reduction in binge
frequency when compared to an active comparison group therapy (which followed a Rogerian
approach) [44]. Behavioural activation compared to delayed treatment did not show differences for
binge eating frequency [27]. In participants with obesity and binge eating, an intervention comparing
a cognitive treatment with a behavioural treatment for obese binge eaters and obese non-binge eaters
showed a higher percentage (67%) for binge abstinence with the cognitive treatment compared to the
behavioural treatment in the post-treatment and six-month follow-up [42].
With regards to long-term follow-up, weight loss is being routinely reported to one year
in obesity trials [18]. This review identified ten studies that reported a follow-up of at least
12 months [17,30,33–36,38,40,43,44]. Considering here only the active interventions and excluding
trials with BWLT treatment (mentioned separately below), no between-group differences in
frequency of binge eating, and/or binge remission rates, and/or BMI reduction were found in four
trials [33,36,38,44]. The 12-month follow-up was not available in Dingemans et al. (2007) because the
delayed treatment participants received the active treatment (CBT) after 24 weeks [40]. The long-term
findings of the study that compared CBT associated or not with exercise and/or maintenance (four
arms) found that the combined exercise groups sustained the significantly better results found at end
of treatment and also at 12-month follow-up for binge eating abstinence and BMI reduction [43].
Five studies compared BWLT with active treatments and/or control group and three of these
were a three-armed trial: BWLT versus CBT-GSH versus IPT [17], BWLT-GSH versus CBT-GSH versus
self-monitoring control [29], and BWLT versus CBT versus CBT plus BWLT [30]. These studies reported
mixed results. Two of these three-armed trials reported no significant difference between the three
groups for binge eating frequency at post-treatment, but better results for binge eating remission and/or
binge frequency for CBT and IPT at the follow-up period; and BWLT (including when combined with
CBT) as more effective in BMI reduction at post-treatment, but not at the follow-up period [17,30]. Grilo
and Masheb (2005) reported different outcomes indicating greater results for binge eating frequency in
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the CBT-GSH group and no differences between groups for BMI reduction [29]. However, they had
no follow-up assessment. Munsch et al. (2007) conducted a trial comparing BWLT versus CBT [34],
and carried out a secondary study with a six-year follow-up, where 52 remained participants from
the original trial were reassessed [35]. Results of the original trial showed better results for binge
remission and binge frequency in CBT group, and better results for BMI reduction in the BWLT group
at end of treatment, with no difference between groups in binge remission and BMI at 12-month
follow-up [34]. Finally, the Munsch’ study, with the longest follow-up (six years), reported attenuation
of the results compared to post-treatment, but still an improvement with medium to large effect sizes
when compared to baseline data [35].
Three trials with follow-up under 12 months reported no differences between the interventions in
binge eating remission/frequency and BMI [28,32,37], and five trials did not have follow-up, or did
not present comparative information [27,29,31,39,41].
Of note, in five trials, weight loss was reported to be significantly greater in those who achieved
and sustained binge remission for a longer-term (at 6- and/or 12-month follow-up) [17,30,34,38,39].
3.4. Results of Meta-Analyses of Studies Comparing BWLT versus CBT
Four trials compared BWLT versus CBT [17,29,30,34] (note Munsch, 2012 was a secondary study
and thus not included in this meta-analyses [35]). When aggregated in meta-analysis, a greater
reduction in binge eating frequency was found with CBT when compared to BWLT at end of treatment
(n = 4 trials, 323 participants; MD 2.04 95% CI, 0.35 to 3.73) (Figure 2).
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Figure 2. Behavioural Weight Loss Therapy versus Cognitive Behavioural Therapy-Effects on binge
eating frequency at the end of treatment in individuals with binge eating disorder.
In three furth r ta-analyses (Figures S1, S2 and S3), there were no significant differ nces for
BMI at end of reatm nt (n = 4 trials, 324 participants; MD −1.01 95% CI, −3.31 to 0.29), binge eating
freque cy at one year follow-up (n = 3 trials, 260 participants; MD 1.87 95% CI, −0.08 to 3.82) or BMI
at one-year follow-up (n = 3 trials, 261 participants; MD −0.2195% CI, −1.52 to 1.09).
Two meta-analyses (Figures S4 and S5) investigated completion rates at end of treatment (n = 4
trials, 375 non-completers; RR 1.16 95% CI, 0.77 to 1.74), and at one-year follow-up (n = 3 trials,
300 non-completers; RR 1.14 95% CI, 0.76 to 1.72) with similar attrition identified for both time-points.
Forest plots of these latter meta-analyses are found in Supplementary Materials.
4. Discussion
This review aimed to examine the findings from trials where psychological therapies were tested
in people with EDs co-morbid with overweight or obesity. All trials identified were of participants
with BED and none included participants with BN or subthreshold BN. The most frequently tested
intervention was CBT, supporting its status in guidelines as the treatment with the strongest level
of evidence to support its use to treat patients with BED [26,46]. When compared with delayed
treatment controls, CBT was found to be superior in reducing binge frequency but not consistently
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so with regards to weight loss, and not when compared to an active treatment control group. DBT
was superior to an active control intervention with regards to reduced binge frequency, but this was
only in one study. Cognitive therapy was superior to a behavioural intervention in reducing binge
frequency in one trial.
The results of the meta-analyses comparing BWLT versus CBT showed that the latter was only
favoured for reducing binge eating in the short term (end of treatment), but not at one-year follow-up.
This meta-analysis concur with a review by McElroy et al. [16] for the effectiveness of CBT in reducing
binge eating frequency in the short-term, but do not support their more supportive findings in the
longer-term . Although BWLT showed greater effects for weight loss at the end of treatment in
comparison to CBT in three trials [17,30,34], no significant differences were found between these
interventions in meta-analyses, in either the short or long term. This is consistent with findings of
other recent reviews [16,47].
The Pendleton trial that compared groups receiving CBT combined to instructions about exercise
principles and/or self-management techniques is of particular note. This study found better results
for reductions in binge days, binge abstinence and BMI in the exercising groups [43]. A systematic
review also described good results for reduction in binge eating frequency and BMI can be reached
when aerobic and yoga exercises are added to the treatment for BED patients [48]. Thus, greater
consideration should likely be given to the addition of exercise in the psychological treatment of
persons with BED associated with overweight or obesity, both in research and in clinical practice.
It would also be important to report in future trials physical health outcomes beyond BMI, including
engagement in and maintenance of exercise.
The consistent finding that weight loss was significantly greater in those who achieved and
sustained binge remission in the long-term is also important to highlight. It indicates the need to
developed approaches for weight loss treatment where reduction, and if possible abstinence of binge
eating is prioritized. Further research into the relationship of these two outcomes is required to confirm
this putative causal relationship.
As described in the beginning of this review, the purpose was to include trials evaluating BN
associated with overweight or obesity. This review found a major gap in evidence for the management
of BN comorbid with obesity, possibly due to existing controversies about potential hazards of diet
restrictions in people with BN. With the rise of BN associated with overweight, there is an urgent
need to develop interventions that focus on these combined conditions and demonstrate that both
conditions can be safely treated.
Limitations of this systematic review are the identification of studies only in the Northern
hemisphere and the underrepresentation of men in trials. In addition, several trials were found
to have notable methodological limitations, including lack of ≥12- month follow-up (9 of 19 trials),
unclear information about selection, performance, detection, attrition and reporting bias. The overall
risk of bias was unclear for majority of trials and risk was most due to lack of blinding in trials.
However, this is unlikely to change the most common result of no significant difference between active
interventions, as blinding would likely reduce differences further. The more promising outcomes, albeit
attenuated, in the six-year follow-up of Munsch et al. [34,35] supports the importance of longer term
outcomes and suggests short term studies may be missing important differences over the longer term.
5. Conclusions
This review provides qualified support for the use of CBT in people with BED comorbid with
obesity/overweight. Whilst CBT was favoured compared to BWLT for binge eating reduction in the
short term, this was not the case for any other outcome and thus there was insufficient evidence to
favour one approach over the other. There was also little qualitative support for CBT versus another
psychological therapy in the longer term. Where CBT is not accessible, BWLT or another psychological
therapy may be used. Adding exercise to CBT may enhance efficacy but more trials are needed.
Higher quality trials with adequate follow-up periods are needed to test the efficacy of psychological
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treatments for BED and for BN with co-morbid overweight or obesity, including trials evaluating binge
eating remission and weight loss in the long term.
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frequency at 12 months follow-up, Figure S3: Forest plot of additional meta-analysis: Mean BMI at 12 months
follow-up, Figure S4: Forest plot of additional meta-analysis: Treatment completion rates at end treatment, Figure
S5: Forest plot of additional meta-analysis: Treatment completion rates at end treatment.
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